Armata Pharmaceuticals
Marina Del Rey
About Armata Pharmaceuticals
Armata Pharmaceuticals is a clinical-stage biotechnology company focused on the development of precisely targeted bacteriophage therapeutics for the treatment of drug-resistant bacterial infections. Antibiotic overuse has led to the marked rise of multidrug-resistant bacteria, putting us on the verge of a post-antibiotic era in which common infections can be serious or life-threatening. Additionally, the use of broad-spectrum antibiotics is known for disrupting the ecology of the human microbiome, leading to disease. The company was founded in 2005 and is based in Marina del Rey, CA, USA.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $320.9M
- Funding stage: IPO
- Last round: Post-IPO Debt (Aug 2025)
- Ticker: nysemkt:ARMP
- Website: armatapharma.com
- Phone: +1 310 665 2928
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/armata-pharmaceuticals-10303 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.